G Poste|D Papahadjopoulos|W J Vail - JoVE Visualize

Showing results (231-240 of 242) with videos related to

Pageof 25

Sort By:

Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001

Tumor targeting using anti-her2 immunoliposomesJ W Park, D B Kirpotin, K Hong, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injuryE H Ohlstein, S A Douglas, C P Sung, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyD Papahadjopoulos, T M Allen, A Gabizon, et al.

Drug Delivery|July 13, 2000

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonismI Petrikovics, W D McGuinn, D Sylvester, et al.

Biochemical Pharmacology|October 15, 1987

SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acidD E Griswold, P J Marshall, E F Webb, et al.

Toxicology and Applied Pharmacology|April 2, 1999

Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomesI Petrikovics, K Hong, G Omburo, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|July 15, 2003

Comparing therapeutic and prophylactic protection against the lethal effect of paraoxonI Petrikovics, D Papahadjopoulos, K Hong, et al.

Gene Therapy|June 27, 2001

Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHRK K Goncz, A Colosimo, B Dallapiccola, et al.

Journal of Medicinal Chemistry|September 1, 1988

Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2C H Kruse, K G Holden, P H Offen, et al.

Circulation Research|February 19, 1998

Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilolT L Yue, X L Ma, X Wang, et al.

Pageof 25

Showing results (231-240 of 242) with videos related to

Sort By:

Pageof 25

Journal of Controlled Release : Official Journal of the Controlled Release Society|August 8, 2001

Tumor targeting using anti-her2 immunoliposomesJ W Park, D B Kirpotin, K Hong, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 1, 1993

Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injuryE H Ohlstein, S A Douglas, C P Sung, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1991

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyD Papahadjopoulos, T M Allen, A Gabizon, et al.

Drug Delivery|July 13, 2000

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonismI Petrikovics, W D McGuinn, D Sylvester, et al.

Biochemical Pharmacology|October 15, 1987

SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acidD E Griswold, P J Marshall, E F Webb, et al.

Toxicology and Applied Pharmacology|April 2, 1999

Antagonism of paraoxon intoxication by recombinant phosphotriesterase encapsulated within sterically stabilized liposomesI Petrikovics, K Hong, G Omburo, et al.

Toxicological Sciences : an Official Journal of the Society of Toxicology|July 15, 2003

Comparing therapeutic and prophylactic protection against the lethal effect of paraoxonI Petrikovics, D Papahadjopoulos, K Hong, et al.

Gene Therapy|June 27, 2001

Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHRK K Goncz, A Colosimo, B Dallapiccola, et al.

Journal of Medicinal Chemistry|September 1, 1988

Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2C H Kruse, K G Holden, P H Offen, et al.

Circulation Research|February 19, 1998

Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilolT L Yue, X L Ma, X Wang, et al.

Pageof 25